Vaishali Pharma peers

·UnclassifiedChart ›

Companies like Vaishali Pharmalatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VAISHALI₹6.87

Vaishali Pharma Limited

· Unclassified
₹ CrorePeersTEMBOTOTALOSWALSEEDSGROBTEABEARDSELLHINDCONCROWNARTNIRMANMcap ₹44.8 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
VAISHALI
FY26
TEMBO
FY26
TOTAL
FY26
OSWALSEEDS
FY26
Peer
Average
Valuation — at last close
P/E21.47×◆ 0.93×14.11×13.92×9.66× +122%
P/B0.65×◆ 0.21×1.21×1.97×1.13× -43%
EV/EBITDA15.05×◆ 2.53×7.75×11.09×7.12× +111%
Market Cap₹44.8 Cr₹95.3 Cr₹110 Cr₹101 Cr₹102 Cr -56%
Growth
Revenue CAGR 3Y—◆ 63.42%1.74%-3.04%20.71%
Revenue CAGR 5Y—◆ 59.59%14.57%—37.08%
Net Income CAGR 3Y—◆ 156.94%14.52%8.17%59.88%
Revenue YoY (latest Q)—21.86%◆ 31.29%19.54%24.23%
Net Income YoY (latest Q)—61.25%40.45%◆ 68.59%56.76%
Profitability
EBITDA Margin3.78%◆ 13.07%2.40%5.85%7.11% -47%
Net Income Margin3.83%◆ 9.01%1.27%2.91%4.40% -13%
Return on Common Equity6.21%◆ 27.53%8.96%15.24%17.24% -64%
Return on Capital Employed4.85%27.36%11.36%◆ 27.78%22.17% -78%
Return on Assets3.57%◆ 10.45%4.32%5.88%6.88% -48%
Credit & Quality
Total Debt/Equity◆ 0.27×0.77×0.42×1.21×0.80× -66%
Interest Coverage1.79×◆ 5.43×2.79×3.01×3.74× -52%
Scale — latest FY
Revenue / Total Income₹109 Cr₹1,090 Cr₹622 Cr₹248 Cr₹653 Cr -83%
Net Income₹4.2 Cr₹98.2 Cr₹7.9 Cr₹7.2 Cr₹37.8 Cr -89%
Total Assets₹123 Cr₹1,306 Cr₹191 Cr₹141 Cr₹546 Cr -77%
EPS₹0.32₹55.11₹4.83₹0.79₹20.24 -98%
Book Value per Share₹10.6₹243.88₹56.1₹5.58₹101.85 -90%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.